Menu

Ségolène PAILLET

Lyon

En résumé

Mes compétences :
Drugs
Mutual Recognition Procedure
Worksharing Procedure
Clinical Development
Centralized Procedure
Clinical Trials
Pharmacy
Pharmaceutical Advertising
Regulatory Variations
Pharmaceutical industry
Pharmacovigilance
National Procedure
Clinical Pharmacy
Regulatory Affairs
E-CTD
Pharmaceutics
CTD
Medical Communications
Fellowships
Experts boards
MEdical Strategy
Medical Affairs
Oncology
Symposia
Regulatory strategy
Endocrinology
Congress
Medical Education

Entreprises

  • Merck - Médical Advisor Fertility

    Lyon 2016 - maintenant
  • Merck Serono - Medical Advisor - Oncology / Endocrinology/Fertility

    Lyon 2014 - 2016 - Clinical trial : inclusions follow up, budget follow up, communications (publications, posters, abstracts, newsletters, investigators meetings,...)
    - Project management in Medical Affairs in order to improve knowledge and communication on the company drugs: communication with medical experts,
    - Fellowships : program constitution with experts, monitoring of registrations, communications,
    - Elaboration of medico-marketing campaigns and medico-marketing strategic plans
    - Constitution of training documents and oral training with medical representants,
    - Medical validation of promotional and non promotional materials,
    - Congress preparation (selection of abstracts, etc) and summaries elaboration,
    - Medical representative for the French affiliate company.
  • Merck Serono - Regulatory Affairs Manager

    Lyon 2013 - 2014 Marketing Authorization:
    - Centralized, Decentralized/Mutual Recognition, National Procedures
    - Worksharing and "grouped variations" procedures
    - Management of CTD, eCTD, Nees formats
    - Constitution of Marketing Authorization dossier and submission to ANSM,
    - Management of variations (all procedures) : constitution of folders, submission to ANSM, update of SmPC and patient leaflet after approval,
    - Proof reading for Artworks
    - "Corporate Lead" responsability for one product with management of approximately 20 countries (enlarged Europe)

    Clinical Trials
    - Constitution of folders for new clinical trials and submission to ANSM and CPP,
    - Management of substantial and non substantial changes: constitution of folders (protocol amendment, update of investigator brochure, etc) with preparation (if needed) of comparative tables, supportive documents, etc, and submission to ANSM.

    Other activities
    - Pharmaceutical advertising control,
    - Regulatory vigilance
    - Translation activities,
    - Participation in updating internal procedures,
    - Relationship with headquarter Merck Darmstadt,
    - Transversality with : Medical information, Pharmacovigilance, Marketing, Regulatory Compliance, Quality assurance
  • GlaxoSmithKline - Regulatory Affairs - Internship of Pharmacy

    Marly-le-Roi 2012 - 2013 November 2012 - May 2013 : Oncology, HIV, Infectious disease, Respiratory, PAH

    May 2013 - November 2013 : NCS, Rheumatology, Urology, Parasitology, Vaccines, Cardiology, Thrombosis

    Marketing Authorization:
    - Centralized, Decentralized/Mutual Recognition, National Procedures
    - Worksharing and "grouped variations" procedures
    - Management of CTD, eCTD, Nees formats
    - Constitution of Marketing Authorization dossier and submission to ANSM,
    - Management of variations (all procedures) : constitution of folders, submission to ANSM, update of SmPC and patient leaflet after approval,
    - Proof reading for Artworks
    - Comparaison of national annexes with GlobalDataSheet of headquarter, and update for harmonization.

    Clinical Trials
    - Constitution of folders for new clinical trials and submission to ANSM,
    - Management of substantial and non substantial changes: constitution of folders (protocol amendment, update of investigator brochure, etc) with preparation (if needed) of comparative tables, supportive documents, etc , and submission to ANSM.

    Other activities
    - Participation in dossier for obtention of reimboursment (with medico-economic department)
    - Regulatory vigilance,
    - Translation activities,
    - Participation in updating internal procedures,
    - Relationship with headquarter GSK UK,
    - Transversality with : Medical information, Clinical Operations, Pharmacovigilance
  • CHU Grenoble - Internship of Pharmacy

    Grenoble 2009 - 2012 May 2012 - November 2012 : Central Sterilization Department
    - Stock management,
    - Traceability monitoring,
    - Audits management,
    - Monitoring and analysis of quality indicators,
    - Versatility in guards.

    November 2011 - May 2012 : Regional Pharmacovigilance Center
    - Answers to questions from health professionals,
    - Collection, evaluation, and documentation of cases,
    - Communications and reports to health authorities.

    May 2011 - November 2011 : Infectious Diseases Department
    - Prescriptions validation,
    - Answers to questions from health professionals, participation on visits and medical staff,
    - Pharmaceutical interviews and patient education,
    - Versatility in guards.

    November 2010 - May 2011 : Hospital Pharmacy – Psychiatry Specialized Hospital of Saint-Egrève
    - Prescriptions validation,
    - Answers to questions from health professionals, participation on medical visits,
    - Drugs and medical devices dispensation,
    - Make lesson to nurse students on antibiotics.
    - Versatility in guards.

    May 2010 - November 2010 : Pneumology Department
    - Prescriptions validation,
    - Answers to questions from health professionals, participation on visits and medical staff,
    - Pharmaceutical interviews and patient education.

    November 2009 - May 2010 : Hospital Pharmacy – Chambéry’s Hospital
    - Pharmacovigilance and matériovigilance management,
    - Participation in marketing of medical devices and tenders,
    - Versatility in guards.

Formations

  • Université Paris XI

    Paris 2012 - 2013 Master 2 Affaires Règlementaires

    Mention Bien
  • UJF Grenoble/UFR De Pharmacie

    Grenoble 2004 - 2013 Doctorat en Pharmacie

    Thèse sur l'impact de la nouvelle réglementation de Pharmacovigilance sur la rédaction/soumission des PSUR/PBRER dans l'industrie pharmaceutique - Mention très honorable - Féliciations du jury

Réseau

Annuaire des membres :